Abstract
This chapter reviews the neuroimaging features of the potential effects of lithium therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Suggested Reading
Fitzgerald RT, et al. Lithium toxicity and PRES: a novel association. J Neuroimaging. 2015;25(1):147–9.
Ikeda Y, et al. Total and regional brain volume reductions due to the syndrome of irreversible lithium-effectuated neurotoxicity (SILENT): a voxel-based morphometric study. Prog Neuro-Psychopharmacol Biol Psychiatry. 2010;34(1):244–6.
Niethammer M, Ford B. Permanent lithium-induced cerebellar toxicity: three cases and review of literature. Mov Disord. 2007;22(4):570–3.
Sanacora G, et al. New understanding of mechanisms of action of bipolar medications. J Clin Psychiatry. 2008;69(suppl 5):22–7.
Soares JC, Boada F, Keshavan MS. Brain lithium measurements with (7)Li magnetic resonance spectroscopy (MRS): a literature review. Eur Neuropsychopharmacol. 2000;10(3):151–8.
Ward ME, et al. Clinical pharmacokinetics of lithium. J Clin Pharmacol. 1994;34:280–5.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Akinola, T., Buch, K., Paul, A. (2022). Lithium. In: Ginat, D.T., Small, J.E., Schaefer, P.W. (eds) Neuroimaging Pharmacopoeia. Springer, Cham. https://doi.org/10.1007/978-3-031-08774-5_36
Download citation
DOI: https://doi.org/10.1007/978-3-031-08774-5_36
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-031-08773-8
Online ISBN: 978-3-031-08774-5
eBook Packages: MedicineMedicine (R0)